| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.72M | $3.33M | $8.04M | $9.70M | $7.82M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $5.90M | $9.15M | $7.05M | $6.27M | $4.24M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$1.18M | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$1.78K | $146.10K | -$63.69K | $31.52K | $88.65K |
| Net Income | -$1.17M | -$5.97M | $1.05M | $3.40M | $3.49M |
| EPS (basic) | -0.0300 | -0.1600 | 0.0300 | 0.1000 | 0.1200 |
| EPS (diluted) | -0.0300 | -0.1600 | 0.0300 | 0.1000 | 0.1200 |
| Shares (diluted) | $37.07M | $37.03M | $32.28M | $34.17M | $30.00M |